Dosages; See below
Combinations; See below
1. Oxytocin / Ergometrine
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Ocin | Opsonin Pharma | Radiance Pharmaceuticals Limited | 5 I.U | 5 | Injection | per vial | KES 80.00 |
| Oxytocin | Win-Medicare | Europa Healthcare Ltd. | 5iu | 10 | Injection | per ampoule | KES 260 |
| Oxytocin | Win-Medicare | Europa Healthcare Ltd. | 10IU | 1 | Injection | per vial | KES 11.5 |
| Oxytocin | Win-Medicare | Europa Healthcare Ltd. | 5iu | 10 | Injection | per vial | KES 375 |
| Syntocinon | Novartis Pharma | Laborex Kenya Eurapharma Ltd | 5iu | 10 | Injection | per vial | KES 1,169.40 |
| Syntocinon | Novartis Pharma | Laborex Kenya Eurapharma Ltd | 5iu | 100 | Injection | per vial | KES 11,694.00 |
| Tocinox | Globe Pharmacy Ltd., | Globe Pharmacy Ltd., | 5iu | 1 | Injection | per vial | KES 12.00 |
| Oxytocin | Laborate | Harley's Limited | 10IU | 1 | Injection | per vial | KES 12.00 |
| Oxytocin | Rotex Medical | Unicorn Pharma (K) Ltd. | 10IU | 10 | Injection | per vial | KES 35.00 |
| Proxytocin | Prism Life Sciences | Galaxy Pharmaceuticals Ltd | 10IU | 1ml | Injection | per vial | KES 15.00 |
| Oxytocin More info | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mode Of Action | Oxytocin acts by increasing intracellular calcium concentrations in the uterine myometrium, which contains receptors specific to oxytocin, thus inducing contractions. It induces lactation by stimulating smooth muscle to help discharge of milk from breasts |
||||||||||||||||||||||||||||||||||
| Drug Indication | Postpartum uterine haemorrhage; medical induction of labour; augmentation of labour; hypotonic uterine inertia; diagnosis of utero-placental insufficiency (oxytocin challenge test); treatment of lactation deficiency (mostly intranasally); diagnosis of foetal distress | ||||||||||||||||||||||||||||||||||
| Precautions | Hypertension; cardiac disease; renal function impairment | ||||||||||||||||||||||||||||||||||
| Contra-Indications | Hypersensitivity to oxytocin; hypertonic uterine patterns; when vaginal delivery is contra-indicated. | ||||||||||||||||||||||||||||||||||
| Side Effects | Fibrinogenaemia; pelvic haematoma; postpartum haemorrhage: allergic reactions; cardiac arrhythmias; hypotension followed by hypertension; uterine rupture; water intoxication; nausea; vomiting. | ||||||||||||||||||||||||||||||||||
| Dosage | Augmentation /induction of labour: IV inf. initially less than 0.5-2 MU/min, increased every 15-60 min by of 1-2 MU/min until adequate uterine activity is established. Treatment of incomplete abortion or therapeutic abortion: IV inf, 10 Units at a rate of 20-40 MU. Treatment of postpartum haemorrhage: IV inf., 10 Units at a rate of 20 - 40 MU after the delivery of the infant(s) and preferably the placenta(s). Diagnosis of utero-placental insufficiency: IV inf., initially 0.5 MU/min, doubled every 20 min as necessary to the effective dose (5-6 MU/Min). When 3 moderate uterine contractions occur with a 10 - minute interval, the infusion is discontinued and baseline and oxytocin-induced fetal heart rate and uterine contraction patterns are compared. | ||||||||||||||||||||||||||||||||||
| Drug Category | DRUGS ACTING ON GENITO-URINARY SYSTEM | ||||||||||||||||||||||||||||||||||
| Drug Sub-Category | Drugs acting on uterus
1. Oxytocin / Ergometrine Brands
|
||||||||||||||||||||||||||||||||||